DK1073634T3 - Fremgangsmåde til fremstilling af enantiomerrent N-methyl-N[(1S)-1-phenyl-2-2((3S)-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamid - Google Patents

Fremgangsmåde til fremstilling af enantiomerrent N-methyl-N[(1S)-1-phenyl-2-2((3S)-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamid

Info

Publication number: DK1073634T3
Authority: DK; Denmark
Prior art keywords: diphenylacetamide; hydroxypyrrolidin; phenyl; ethyl; methyl
Prior art date: 1998-04-20

Application number

DK99923421T

Other languages

Danish (da)

English (en)

Inventor

Andreas Bathe

Bernd Helfert

Ingeborg Stein

Karl-August Ackermann

Rudolf Gottschlich

Jens Budak

Original Assignee

Merck Patent Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-20

Filing date

1999-04-16

Publication date

2006-01-09

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7865063&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1073634(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-04-16 Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh

2006-01-09 Application granted granted Critical

2006-01-09 Publication of DK1073634T3 publication Critical patent/DK1073634T3/da

Links

125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B35/00—Reactions without formation or introduction of functional groups containing hetero atoms, involving a change in the type of bonding between two carbon atoms already directly linked
- C07B35/02—Reduction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B43/00—Formation or introduction of functional groups containing nitrogen
- C07B43/06—Formation or introduction of functional groups containing nitrogen of amide groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Hematology (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pyrrole Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

DK99923421T 1998-04-20 1999-04-16 Fremgangsmåde til fremstilling af enantiomerrent N-methyl-N[(1S)-1-phenyl-2-2((3S)-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamid DK1073634T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19817393		1998-04-20
DE19827633A DE19827633A1 (de)	1998-04-20	1998-06-20	Verfahren zur Herstellung von enantiomerenreinem N-Methyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamid

Publications (1)

Publication Number	Publication Date
DK1073634T3 true DK1073634T3 (da)	2006-01-09

Family

ID=7865063

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK99923421T DK1073634T3 (da)	1998-04-20	1999-04-16	Fremgangsmåde til fremstilling af enantiomerrent N-methyl-N[(1S)-1-phenyl-2-2((3S)-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamid
DK05016750.1T DK1607090T3 (da)	1998-04-20	1999-04-16	Asimadolin til behandling af irritabel tyktarm (Irritable Bowel Syndrome)

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DK05016750.1T DK1607090T3 (da)	1998-04-20	1999-04-16	Asimadolin til behandling af irritabel tyktarm (Irritable Bowel Syndrome)

Country Status (27)

Country	Link
US (1)	US6344566B1 (cs)
EP (2)	EP1607090B1 (cs)
JP (1)	JP4688292B2 (cs)
KR (1)	KR100649175B1 (cs)
CN (2)	CN1310884C (cs)
AR (2)	AR019080A1 (cs)
AT (2)	ATE303361T1 (cs)
AU (2)	AU761721B2 (cs)
BR (1)	BR9909731A (cs)
CA (1)	CA2329210C (cs)
CY (1)	CY1112314T1 (cs)
CZ (1)	CZ301121B6 (cs)
DE (2)	DE19827633A1 (cs)
DK (2)	DK1073634T3 (cs)
ES (2)	ES2251194T3 (cs)
HU (1)	HUP0101600A3 (cs)
MY (1)	MY120471A (cs)
NO (1)	NO317984B1 (cs)
PL (1)	PL206969B1 (cs)
PT (1)	PT1607090E (cs)
RU (1)	RU2298549C2 (cs)
SI (2)	SI1607090T1 (cs)
SK (2)	SK288016B6 (cs)
TW (1)	TWI249524B (cs)
UA (1)	UA73472C2 (cs)
WO (1)	WO1999054298A1 (cs)
ZA (1)	ZA200006689B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10259245A1 (de) *	2002-12-17	2004-07-01	Merck Patent Gmbh	Derivate des Asimadolins mit kovalent gebundenen Säuren
JP2007509865A (ja) *	2003-10-30	2007-04-19	ティオガファーマシュウティカルズ，インコーポレイテッド	神経障害の治療における選択的オピエート受容体調節物質の使用
US20070160559A1 (en) *	2006-01-12	2007-07-12	Roszell James A	Skin disinfectant composition and methods for using
CN101677997B (zh) *	2007-03-30	2012-05-09	泰奥加制药公司	用于治疗腹泻型和交替型肠易激综合征的κ-阿片剂激动剂
CN103664727A (zh) *	2013-12-19	2014-03-26	无锡万全医药技术有限公司	一种一锅法制备1-[(3s)-3-羟基吡咯烷-1-基]-(2s)-2-甲氨基-2-苯基乙烷的工艺
CN103772257A (zh) *	2013-12-31	2014-05-07	无锡万全医药技术有限公司	一种制备2-((3s)-3-羟基吡咯烷-1-基)-(1s)-1-苯乙基氨基甲酸酯的方法
US10736871B2 (en)	2015-04-01	2020-08-11	Cedars-Sinai Medical Center	Anti-methanogenic lovastatin analogs or derivatives and uses thereof
CN112574068A (zh) *	2020-11-17	2021-03-30	万华化学（宁波）有限公司	一种低色号高稳定性碳化二亚胺改性异氰酸酯的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5232978A (en) *	1988-12-23	1993-08-03	Merck Patent Gesellschaft Mit Beschrankter Haftung	1-(2-arylethyl)-pyrrolidines
DE4034785A1 (de) *	1990-11-02	1992-05-07	Merck Patent Gmbh	1-(2-arylethyl)-pyrrolidine
DE4215213A1 (de) *	1992-05-09	1993-11-11	Merck Patent Gmbh	Arylacetamide
DE4425071C2 (de) *	1994-07-15	1996-08-29	Degussa	Verfahren zur Herstellung optisch aktiver Pyrrolidine mit hoher Enantiomerenreinheit
DE19523502A1 (de) *	1995-06-28	1997-01-02	Merck Patent Gmbh	Kappa-Opiatagonisten für entzündliche Darmerkrankungen
DE19531464A1 (de) *	1995-08-26	1997-02-27	Merck Patent Gmbh	N-Methyl-N-[(1S-)-1-phenyl-2-((3S)-3-hydroxypyrrolidin 1-yl-)-ethyl]-2,2-diphenyl-acetamid
US5968968A (en) *	1996-07-24	1999-10-19	Warner-Lambert Company	Diphenyl-cyclopropenes as selective K-agonists
DE19647538A1 (de) *	1996-11-16	1998-05-20	Merck Patent Gmbh	Verfahren zur Herstellung von enantiomerenreinem N-Methyl-N-[1-phenyl-2-(-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamid

1998
- 1998-06-20 DE DE19827633A patent/DE19827633A1/de not_active Withdrawn
1999
- 1999-04-16 AU AU40311/99A patent/AU761721B2/en not_active Ceased
- 1999-04-16 CZ CZ20003860A patent/CZ301121B6/cs not_active IP Right Cessation
- 1999-04-16 KR KR1020007011480A patent/KR100649175B1/ko not_active Expired - Fee Related
- 1999-04-16 CN CNB998052469A patent/CN1310884C/zh not_active Expired - Fee Related
- 1999-04-16 AT AT99923421T patent/ATE303361T1/de active
- 1999-04-16 SI SI9931065T patent/SI1607090T1/sl unknown
- 1999-04-16 AT AT05016750T patent/ATE527999T1/de active
- 1999-04-16 JP JP2000544639A patent/JP4688292B2/ja not_active Expired - Fee Related
- 1999-04-16 HU HU0101600A patent/HUP0101600A3/hu unknown
- 1999-04-16 DK DK99923421T patent/DK1073634T3/da active
- 1999-04-16 AR ARP990101758A patent/AR019080A1/es active IP Right Grant
- 1999-04-16 ES ES99923421T patent/ES2251194T3/es not_active Expired - Lifetime
- 1999-04-16 SI SI9930848T patent/SI1073634T1/sl unknown
- 1999-04-16 UA UA2000116543A patent/UA73472C2/uk unknown
- 1999-04-16 PL PL343556A patent/PL206969B1/pl unknown
- 1999-04-16 EP EP05016750A patent/EP1607090B1/de not_active Expired - Lifetime
- 1999-04-16 BR BR9909731-1A patent/BR9909731A/pt not_active Application Discontinuation
- 1999-04-16 SK SK5006-2008A patent/SK288016B6/sk not_active IP Right Cessation
- 1999-04-16 DK DK05016750.1T patent/DK1607090T3/da active
- 1999-04-16 WO PCT/EP1999/002574 patent/WO1999054298A1/de not_active Ceased
- 1999-04-16 EP EP99923421A patent/EP1073634B1/de not_active Expired - Lifetime
- 1999-04-16 RU RU2000128663/04A patent/RU2298549C2/ru not_active IP Right Cessation
- 1999-04-16 CN CNA2006100710951A patent/CN1846696A/zh active Pending
- 1999-04-16 SK SK1557-2000A patent/SK286442B6/sk not_active IP Right Cessation
- 1999-04-16 DE DE59912502T patent/DE59912502D1/de not_active Expired - Lifetime
- 1999-04-16 ES ES05016750T patent/ES2375384T3/es not_active Expired - Lifetime
- 1999-04-16 PT PT05016750T patent/PT1607090E/pt unknown
- 1999-04-16 CA CA002329210A patent/CA2329210C/en not_active Expired - Fee Related
- 1999-04-19 MY MYPI99001517A patent/MY120471A/en unknown
- 1999-04-20 TW TW088106298A patent/TWI249524B/zh not_active IP Right Cessation
2000
- 2000-10-19 NO NO20005259A patent/NO317984B1/no not_active IP Right Cessation
- 2000-11-16 ZA ZA200006689A patent/ZA200006689B/en unknown
2001
- 2001-01-26 US US09/647,813 patent/US6344566B1/en not_active Expired - Lifetime
2003
- 2003-09-29 AU AU2003248428A patent/AU2003248428B2/en not_active Ceased
2008
- 2008-05-06 AR ARP080101910A patent/AR066455A2/es unknown
2012
- 2012-01-05 CY CY20121100015T patent/CY1112314T1/el unknown

Also Published As

Publication number	Publication date
WO1999054298A1 (de)	1999-10-28
NO20005259L (no)	2000-10-19
PL343556A1 (en)	2001-08-27
MY120471A (en)	2005-10-31
CN1297435A (zh)	2001-05-30
DE19827633A1 (de)	1999-10-21
AU4031199A (en)	1999-11-08
JP2002512223A (ja)	2002-04-23
EP1073634B1 (de)	2005-08-31
ZA200006689B (en)	2002-02-18
SK288016B6 (sk)	2012-11-05
ES2375384T3 (es)	2012-02-29
AU2003248428B2 (en)	2005-10-20
KR20010042750A (ko)	2001-05-25
PT1607090E (pt)	2012-01-10
TWI249524B (en)	2006-02-21
DK1607090T3 (da)	2012-01-30
SK286442B6 (sk)	2008-10-07
KR100649175B1 (ko)	2006-11-24
AR019080A1 (es)	2001-12-26
JP4688292B2 (ja)	2011-05-25
ES2251194T3 (es)	2006-04-16
NO317984B1 (no)	2005-01-17
ATE527999T1 (de)	2011-10-15
UA73472C2 (en)	2005-08-15
HUP0101600A2 (hu)	2001-09-28
CA2329210A1 (en)	1999-10-28
HUP0101600A3 (en)	2002-12-28
DE59912502D1 (de)	2005-10-06
ATE303361T1 (de)	2005-09-15
CA2329210C (en)	2008-03-04
SI1073634T1 (sl)	2006-02-28
RU2298549C2 (ru)	2007-05-10
SK15572000A3 (sk)	2001-05-10
US6344566B1 (en)	2002-02-05
CN1310884C (zh)	2007-04-18
CY1112314T1 (el)	2015-12-09
NO20005259D0 (no)	2000-10-19
AR066455A2 (es)	2009-08-19
CZ301121B6 (cs)	2009-11-11
EP1607090A1 (de)	2005-12-21
AU761721B2 (en)	2003-06-05
EP1607090B1 (de)	2011-10-12
SI1607090T1 (sl)	2012-01-31
BR9909731A (pt)	2000-12-19
AU2003248428A1 (en)	2003-11-06
HK1039111A1 (en)	2002-04-12
CN1846696A (zh)	2006-10-18
CZ20003860A3 (cs)	2001-01-17
EP1073634A1 (de)	2001-02-07
PL206969B1 (pl)	2010-10-29

Publication	Publication Date	Title
DK1123284T3 (da)	2003-04-28	Fremgangsmåde til fremstilling af citalopram
DK1105382T3 (da)	2002-05-27	Fremgangsmåde til fremstilling af citalopram
DK1159274T3 (da)	2003-07-21	Fremgangsmåde til fremstilling af citalopram
DK1181272T3 (da)	2002-12-30	Fremgangsmåde til fremstilling af rent citalopram
DK1181713T3 (da)	2005-01-31	Fremgangsmåde til fremstilling af rent citalopram
DK1226188T3 (da)	2005-03-29	Fremgangsmåde til fremstilling af mannichaddukter, som indeholder polyisobutenphenol
DK1772141T3 (da)	2009-07-20	Fremgangsmåde til gennemföring af krystallisation i fast tilstand
DK1161426T3 (da)	2007-10-08	Fremgangsmåde til fremstilling af furfural
DK1008577T4 (da)	2006-06-06	Fremgangsmåde til fremstilling af methanol
AU4143300A (en)	2000-11-17	Cyclic amide compounds, process for the preparation of the same and uses thereof
DK0937055T3 (da)	2002-07-29	Fremgangsmåde til fremstilling af d,I-alfa-tocopherol
DK1309582T3 (da)	2005-03-14	Fremgangsmåde til fremstilling af citalopram
DK1140886T3 (da)	2003-07-28	Fremgangsmåde til fremstilling af 5-cyanophtalid
DK1385826T3 (da)	2007-04-30	Fremgangsmåde til fremstilling af (S)-(+)- og (R)-(-)-10,11-dihydro-10-hydroxy-5H-dibenz/b,f/azapin-5-carboxamid
DK1958938T3 (da)	2011-07-25	Fremgangsmåde til fremstilling af 10,11-dihydro-10-oxo-5H-dibenz[b,f]azepin-5-carboxamid
BR9603540A (pt)	1998-05-12	n-metil-n-((1s)-2-((3s)-3-hidróxl-pirrolidin-1-il)etil)-2,2-difenilacetamida
AU5067799A (en)	2000-02-14	Process for preparing optically pure (s)-3,4-dihydroxybutyric acid derivatives
DK0378455T3 (da)	1994-09-05	Fremgangsmåde til fremstilling af derivater af (+)-(2S,3S)-3-hydroxy-2-(4-methoxyphenyl)-2,3-dihydro-5H-1,5-benzothiazepine-4-on
DK1296970T3 (da)	2008-07-14	Fremgangsmåde til fremstilling af citalopram
DK0973769T3 (da)	2004-12-13	Fremgangsmåde til fremstilling af eprosartan
DK0927766T3 (da)	2006-09-04	Enzymatisk fremgangsmåde til fremstilling af (S)-cyanhydriner
NO20005259L (no)	2000-10-19	Fremgangsmåte for fremstilling av enantiomerrent N-metyl-N- [(1S)-1-fenyl-2-((3S)-3-hydroksypyrrolidin-1-yl)etyl]-2,2- difenylacetamid
DK1228056T3 (da)	2005-01-24	Fremgangsmåde til fremstilling af citalopram
DK1075473T3 (da)	2007-11-05	Fremgangsmåde til fremstilling af 1,3-disubstituerede-4-oxocykliske urinstoffer
DK0906255T3 (da)	2001-08-13	Fremgangsmåde til fremstilling af enantiomert ren azetidin-2-carboxylsyre